3月24日 的 Imprivata ID 應用程式分析
Imprivata ID
- Imprivata, Inc
- Google Play 商店
- 免費版
- 醫療
Imprivata ID is a secure authentication application that helps improve clinical workflows for medical professionals for electronic prescribing of controlled substances (EPCS), remote network access, and others.
For EPCS, Imprivata ID enables Hands Free Authentication, a breakthrough solution that delivers exceptional speed, security, and convenience for providers while meeting DEA two-factor authentication requirements for EPCS. Instead of typing a manual token code, Hands Free Authentication wirelessly retrieves and verifies a one-time password from the Imprivata ID application on the user’s mobile device, even if it is locked and/or in the user’s pocket, which delivers unparalleled speed and convenience with minimal impact to clinical workflows.
For remote network access, Imprivata ID enables fast, convenient push notifications. Users receive a notification on their mobile phone asking them to verify their identity. The user simply swipes the notification from the lock screen of their device and taps “Approve,” and the second factor of authentication is complete.
Imprivata ID uses Foreground Service for communication between the app and a Bluetooth dongle connected to a Windows PC, as Imprivata ID acts as a key for user authentications in Windows applications when the Android device is in close proximity to the PC.
Please note: To use Imprivata ID, the healthcare provider organization needs to purchase a license for Imprivata Confirm ID (as well as a license for Hands Free Authentication if using that feature). Visit https://www.imprivata.com/imprivata-confirm-id for more information.
Imprivata ID 使用排名
基於 Similarweb 的算法,根據過去 28 天的安裝數和活躍用戶數進行計算。
所有類別 在
美國#2,703
醫療 在
美國#61
每日活躍使用者
通過查看Imprivata ID 的下載量和每日活躍用戶數,分析 Imprivata ID 用戶的使用模式。
位使用者
通過查看Imprivata ID 的下載量和每日活躍用戶數,分析 Imprivata ID 用戶的使用模式。
解鎖每日活躍使用者1月2月3月
隨時間變化的 Imprivata ID 排名統計
Similarweb 的使用排名和Google Play 商店Imprivata ID排名
使用排名
商店排名
排名
用戶興趣和熱門類別
Imprivata ID用戶使用的熱門類別和應用程式
3月 24, 2025